The Indian Council of Medical Research (ICMR) has selected 21 hospitals for clinical trails of plasma therapy, a technique where antibodies of cured COVID-19 patients are used to treat critical coronavirus patients. Most of the hospitals are from Maharashtra, followed by Gujarat, and Rajasthan.
AS per a ET report, a total of five hospitals have been selected from Maharashtra, four from Gujarat, and two each from Rajasthan, Tamil Nadu, Madhya Pradesh and Uttar Pradesh, and one each in Punjab, Karnataka, Telangana and Chandigarh to initiate the clinical trials.
Plasma therapy holds huge significance as India is battling with test kits. This technique involves separation of plasma from blood of cured patient and then using antibodies to treat COVID-19 patients.
Approximately 400 ml plasma is drawn out from one person, which is used to treat two patients.
Sir H N Reliance Foundation Hospital and Research Centre of Mumbai has been chosen for the trials. The multi-centre trials would be conducted on 452 patients across centres.
ICMR’s project is called PLACID — Phase-II Open Label Randomised Controlled Trial to Assess the Safety and Efficacy of Convalescent Plasma to Limit Covid-19 Associated Complications in Moderate Disease, the report said.